Loading clinical trials...
Loading clinical trials...
Heart failure is the most common cause of death of patients on chronic hemodialysis treatment, and to date there is no effective therapy for the treatment of this comorbidity in this group of patients...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
University Clinical Hospital Mostar
NCT07462741 · Hemodialysis Patient, Diabetes Foot Care
NCT07219511 · Heart, Heart Failure With Preserved Ejection Fraction (HFPEF)
NCT07272902 · Atrial Fibrillation (AF), Heart Failure With Mildly Reduced Ejection Fraction, and more
NCT06978127 · Chronic Kidney Disease Requiring Hemodialysis
NCT07153939 · Chronic Kidney Disease, Hemodialysis Access, and more
University Clinical Hospital Mostar
Mostar
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions